Why the study?
Cardiac tamponade is a rare presentation in breast cancer and may be associated with poor prognosis, prompting a review of patient characteristics and survival outcomes.
Population
64 cases of breast cancer patients who developed cardiac tamponade from 16 articles
Design
Systematic review
Authors
Loading...
Clinicians should consider tamponade in symptomatic breast cancer patients; leaves open need for prospective data on incidence and outcomes.
In patients with breast cancer, cardiac tamponade is a rare complication typically treated initially with pericardiocentesis and is associated with a median survival of 13 months.
Ilerhunmwuwa et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: